Neoadjuvant treatment in oesophageal cancer: The needs for future trials

European Journal of Surgical Oncology

Volumn 22, Issue 4, 1996, Pages 323-325

  Kok, Tjebbe C ^a   Tilanus, Hugo W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Neoadjuvant treatment; Oesophageal cancer; Trials

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; VINDESINE;

ARTICLE; BONE MARROW; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CANCER; HUMAN; PRIORITY JOURNAL;

EID: 0029763757     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)90066-9     Document Type: Article

References (30)

1. Earlam R, Cunha-Melo J. Oesophageal squamous cell carinoma: I. A critical review of radiotherapy. Br J Surg 1980; 67: 381-90.
2. Müller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
3. Bosch A, Frias Z, Caldwell WL, Jaeschke WH. Autopsy findings in carcinoma of the esophagus. Acta Radial Oncol 1979; 18: 103-335.
4. Mandard AM, Chasle J, Marnay J, et al. Autopsy findings in 111 cases of esophageal cancer. Cancer 1981; 48: 329-35.
5. Chan KW, Chan EY, Chan CW. Carcinoma of the esophagus. An autopsy study of 231 cases. Pathology 1986; 18: 400-5.
6. Law SYK, Fok M, Wong J. Patterns of recurrence after oesophagectomy for cancer. Clinical Implications. Abstracts volume, 6th World Congress of the ISDE, Milan, Italy, August 23-26, 1995: 26.
7. Ajani JA. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 1994; 4: 474-82.
8. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 1994; 12: 970-4.
9. Muggia FM, Gill I. Primary chemotherapy. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles & practice of oncology updates. Philadelphia, PA: Lippincott 1990: 1-12.
10. Harris DT, Mastrangelo MJ. Theory and application of early systemic therapy. Semin Oncol 1991; 18: 493-503.
11. Schatten WE. An experimental study of postoperative tumor metastases I. Growth of pulmonary metastases following total removal of primary leg tumor. Cancer 1958; 11: 455-9.
12. Simpson-Herren L, Sandford AH, Holmquist JP. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 1976; 60: 1749-60.
13. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983; 43: 1488-92.
14. Pendergast WJ Jr, Drake WP, Mardiney Mr Jr. A proper sequence for the treatment of B16 melaṅoma: chemotherapy, surgery and immunotherapy. J Natl Cancer Inst 1976; 57: 539-44.
15. Ilson DH, Kelsen DP. Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 1994; 4: 493-507.
16. Vignoud J, Visset J, Paineau J, Le Neel JC, Cuilliere P, Cussac A. Preoperative chemotherapy in squamous cell carcinoma of the esophagus: clinical and pathological analysis, 48 cases. Ann Oncol 1990; 1 (Suppl.): 45.
17. Ajani JA, Ryan B, Rich TA, et al. Prolonged chemotherapy for localised squamous carcinoma of the esophagus. Eur J Cancer 1992; 28A: 880-4.
18. Hilgrenberg AD, Carey RW, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988; 45: 357-63.
19. Kies MS. Rosen ST, Tsang TK. Shetty R, Schneider PA, Wallemark CB, Shields TW. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal . Cancer 1987; 60: 2156-60.
20. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and post-operative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the oesophagus. J Thorac Cardiovasc Surg 1988; 96: 242-8.
21. Schlag P. Randomisierte Studie zur präoperativen Chemo- therapie beim Plattenepithelcarcinom des Oesophagus. Chirurg 1992; 63: 709-14.
22. Nygaard K, Hagen S, Hansen HS, et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-9.
23. Fok M, Law S, Wong J. Prospective randomised study on preoperative chemotherapy for resectable intrathoracic squamous cancer of the oesophagus. Abstracts volume, 6th World Congress of the ISDE. Milan, Italy, August 23-26, 1995: 139.
24. Kok TC, Tilanus HW, Lanschot van J, Siersema PD, Overhagen van H, Bosman F. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: a 3rd interim report. Abstracts volume, 6th World Congress of the ISDE. Milan, Italy, August 23-26, 1995: 139.
25. Yokes EE. Interactions of chemotherapy and radiation. Semin Oncol 1993; 20: 70-9.
26. Poplin E, Fleming T, Leichman L, et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 1987; 5: 622-8.
27. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
28. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
29. Ajani JA, Roth JA, Ryan MB, Putnam JB, Pazdur R, Levin B, Gutterman JU, McMurtrey M. Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 1993; 1: 22-8.
30. Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM, Kelsen DP. Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994; 14: 1086-91.